Log in

NASDAQ:IMMUImmunomedics News Headlines

$42.23
-1.11 (-2.56 %)
(As of 07/31/2020 04:00 PM ET)
Add
Compare
Today's Range
$41.15
Now: $42.23
$43.78
50-Day Range
$30.31
MA: $38.26
$43.91
52-Week Range
$8.80
Now: $42.23
$44.48
Volume1.97 million shs
Average Volume2.14 million shs
Market Capitalization$9.75 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.36

Headlines

Immunomedics (NASDAQ IMMU) News Headlines

Source:
DateHeadline
Immunomedics, Inc. (NASDAQ:IMMU) Expected to Post Quarterly Sales of $23.14 MillionImmunomedics, Inc. (NASDAQ:IMMU) Expected to Post Quarterly Sales of $23.14 Million
www.americanbankingnews.com - August 3 at 1:52 AM
-$0.35 EPS Expected for Immunomedics, Inc. (NASDAQ:IMMU) This Quarter-$0.35 EPS Expected for Immunomedics, Inc. (NASDAQ:IMMU) This Quarter
www.americanbankingnews.com - August 1 at 3:56 PM
Immunocytokines Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2024Immunocytokines Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2024
www.marketwatch.com - July 31 at 8:53 AM
Immunomedics, Inc. (NASDAQ:IMMU) Given Consensus Recommendation of "Buy" by BrokeragesImmunomedics, Inc. (NASDAQ:IMMU) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 29 at 1:03 PM
Immunomedics, Inc. to Post FY2020 Earnings of ($1.17) Per Share, Jefferies Financial Group Forecasts (NASDAQ:IMMU)Immunomedics, Inc. to Post FY2020 Earnings of ($1.17) Per Share, Jefferies Financial Group Forecasts (NASDAQ:IMMU)
www.americanbankingnews.com - July 29 at 11:01 AM
Immunomedics (IMMU) Scheduled to Post Quarterly Earnings on WednesdayImmunomedics (IMMU) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 29 at 8:45 AM
Immunomedics (NASDAQ:IMMU) Shares Gap Up  After Analyst UpgradeImmunomedics (NASDAQ:IMMU) Shares Gap Up After Analyst Upgrade
www.marketbeat.com - July 28 at 1:54 PM
Immunomedics Analyst Says Trodelvy Likely To Capture 50% Market Share - Yahoo FinanceImmunomedics Analyst Says Trodelvy Likely To Capture 50% Market Share - Yahoo Finance
finance.yahoo.com - July 27 at 7:12 PM
Immunomedics (NASDAQ:IMMU) Trading Up 5.1% Following Analyst UpgradeImmunomedics (NASDAQ:IMMU) Trading Up 5.1% Following Analyst Upgrade
www.marketbeat.com - July 27 at 6:26 PM
Read This Before Selling Immunomedics, Inc. (NASDAQ:IMMU) SharesRead This Before Selling Immunomedics, Inc. (NASDAQ:IMMU) Shares
finance.yahoo.com - July 27 at 2:11 PM
Immunomedics (NASDAQ:IMMU) PT Raised to $55.00Immunomedics (NASDAQ:IMMU) PT Raised to $55.00
www.americanbankingnews.com - July 27 at 9:56 AM
UPDATE: Immunomedics (IMMU) PT Raised to $55 at Jefferies; Survey Suggests Strong Trodelvy Launch - StreetInsider.comUPDATE: Immunomedics (IMMU) PT Raised to $55 at Jefferies; 'Survey Suggests Strong Trodelvy Launch' - StreetInsider.com
www.streetinsider.com - July 27 at 9:11 AM
Immunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020 - GlobeNewswireImmunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020 - GlobeNewswire
www.globenewswire.com - July 27 at 9:11 AM
Immunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020Immunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020
finance.yahoo.com - July 27 at 9:11 AM
Jefferies Financial Group Raises Immunomedics (NASDAQ:IMMU) Price Target to $55.00Jefferies Financial Group Raises Immunomedics (NASDAQ:IMMU) Price Target to $55.00
www.marketbeat.com - July 27 at 8:26 AM
Immunomedics (NASDAQ:IMMU) Shares Gap Down to $42.24Immunomedics (NASDAQ:IMMU) Shares Gap Down to $42.24
www.americanbankingnews.com - July 24 at 8:24 PM
IMMU Crosses Above Average Analyst TargetIMMU Crosses Above Average Analyst Target
www.nasdaq.com - July 21 at 7:12 PM
Immunomedics (NASDAQ:IMMU) Sets New 1-Year High at $43.00Immunomedics (NASDAQ:IMMU) Sets New 1-Year High at $43.00
www.americanbankingnews.com - July 20 at 10:54 AM
Immunomedics (IMMU) Buy Rating Reiterated at HC WainwrightImmunomedics' (IMMU) Buy Rating Reiterated at HC Wainwright
www.americanbankingnews.com - July 16 at 5:37 AM
Immunomedics Extends Deal With Roche for Two New Studies - NasdaqImmunomedics Extends Deal With Roche for Two New Studies - Nasdaq
www.nasdaq.com - July 14 at 12:31 PM
Immunomedics expands Roche partnership with two new trials - Seeking AlphaImmunomedics expands Roche partnership with two new trials - Seeking Alpha
seekingalpha.com - July 14 at 2:26 AM
Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers - GlobeNewswireImmunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers - GlobeNewswire
www.globenewswire.com - July 13 at 9:25 PM
Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung CancersImmunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers
finance.yahoo.com - July 13 at 9:25 PM
 Analysts Expect Immunomedics, Inc. (NASDAQ:IMMU) Will Post Quarterly Sales of $23.14 Million Analysts Expect Immunomedics, Inc. (NASDAQ:IMMU) Will Post Quarterly Sales of $23.14 Million
www.americanbankingnews.com - July 11 at 1:30 AM
 Brokerages Expect Immunomedics, Inc. (NASDAQ:IMMU) to Post -$0.33 Earnings Per Share Brokerages Expect Immunomedics, Inc. (NASDAQ:IMMU) to Post -$0.33 Earnings Per Share
www.americanbankingnews.com - July 9 at 7:50 PM
Q1 2021 EPS Estimates for Immunomedics, Inc. (NASDAQ:IMMU) Lifted by AnalystQ1 2021 EPS Estimates for Immunomedics, Inc. (NASDAQ:IMMU) Lifted by Analyst
www.americanbankingnews.com - July 9 at 6:10 AM
Immunomedics: A Solid Cancer Research Play - Yahoo FinanceImmunomedics: A Solid Cancer Research Play - Yahoo Finance
finance.yahoo.com - July 8 at 7:35 PM
Is Immunomedics (IMMU) Outperforming Other Medical Stocks This Year? - NasdaqIs Immunomedics (IMMU) Outperforming Other Medical Stocks This Year? - Nasdaq
www.nasdaq.com - July 7 at 1:05 PM
BRIEF-Immunomedics Announces Positive Results From Study Of Trodelvy™ In Previously-Treated Patients With Metastatic Triple-Negative Breast CancerBRIEF-Immunomedics Announces Positive Results From Study Of Trodelvy™ In Previously-Treated Patients With Metastatic Triple-Negative Breast Cancer
www.reuters.com - July 7 at 8:05 AM
Immunomedics Shares Surge YTD on Cancer Drug ApprovalImmunomedics' Shares Surge YTD on Cancer Drug Approval
finance.yahoo.com - July 7 at 8:05 AM
Immunomedics Positive Cancer Data, And Other News: The Good, Bad And Ugly Of BiopharmaImmunomedics Positive Cancer Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 7 at 8:05 AM
BLU Plunges On RELIEF Data, FDA Places CLLS Trial On Hold, IMMU Hits New High, OTIC Music To Ears BLU Plunges On RELIEF Data, FDA Places CLLS' Trial On Hold, IMMU Hits New High, OTIC Music To Ears
www.rttnews.com - July 7 at 5:58 AM
Immunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVY™ in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer (mTNBC) - GlobeNewswireImmunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVY™ in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer (mTNBC) - GlobeNewswire
www.globenewswire.com - July 7 at 3:04 AM
Immunomedics (IMMU) Phase 3 ASCENT Study of TRODELVY in Previously-Treated Patients with mTNBC Met Primary Endpoint - StreetInsider.comImmunomedics (IMMU) Phase 3 ASCENT Study of TRODELVY in Previously-Treated Patients with mTNBC Met Primary Endpoint - StreetInsider.com
www.streetinsider.com - July 6 at 10:02 PM
Shares of Immunomedics jump on positive confirmatory data for its breast-cancer drug - MarketWatchShares of Immunomedics jump on positive confirmatory data for its breast-cancer drug - MarketWatch
www.marketwatch.com - July 6 at 10:02 PM
Immunomedics Shares March Higher, Can It Continue?Immunomedics' Shares March Higher, Can It Continue?
finance.yahoo.com - July 6 at 12:01 PM
Immunomedics antibody-drug conjugate successful in late-stage breast cancer studyImmunomedics antibody-drug conjugate successful in late-stage breast cancer study
seekingalpha.com - July 6 at 12:01 PM
Immunomedics' Shares March Higher, Can It Continue?Immunomedics' Shares March Higher, Can It Continue?
finance.yahoo.com - July 6 at 12:01 PM
Immunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVY™ in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer (mTNBC)Immunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVY™ in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer (mTNBC)
finance.yahoo.com - July 6 at 12:01 PM
Immunomedics' Shares Surge YTD on Cancer Drug ApprovalImmunomedics' Shares Surge YTD on Cancer Drug Approval
finance.yahoo.com - July 6 at 12:01 PM
Shares of Immunomedics jump on positive confirmatory data for its breast-cancer drugShares of Immunomedics jump on positive confirmatory data for its breast-cancer drug
finance.yahoo.com - July 6 at 12:01 PM
Immunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical Update - Yahoo FinanceImmunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical Update - Yahoo Finance
finance.yahoo.com - July 4 at 9:34 AM
Immunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical Update - StreetInsider.comImmunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical Update - StreetInsider.com
www.streetinsider.com - July 2 at 7:26 PM
Immunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical UpdateImmunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical Update
finance.yahoo.com - July 2 at 7:26 PM
Shareholder Alert: Robbins LLP Announces It Is Investigating Immunomedics, Inc. (IMMU) for Misleading Shareholders - Business WireShareholder Alert: Robbins LLP Announces It Is Investigating Immunomedics, Inc. (IMMU) for Misleading Shareholders - Business Wire
www.businesswire.com - June 29 at 6:30 PM
Shareholder Alert: Robbins LLP Announces It Is Investigating Immunomedics, Inc. (IMMU) for Misleading ShareholdersShareholder Alert: Robbins LLP Announces It Is Investigating Immunomedics, Inc. (IMMU) for Misleading Shareholders
finance.yahoo.com - June 29 at 6:29 PM
Shareholder Alert: Robbins LLP Reminds Investors Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss - Yahoo FinanceShareholder Alert: Robbins LLP Reminds Investors Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss - Yahoo Finance
finance.yahoo.com - June 24 at 11:07 PM
Shareholder Alert: Robbins LLP Reminds Investors Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to DismissShareholder Alert: Robbins LLP Reminds Investors Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss
finance.yahoo.com - June 24 at 6:06 PM
Royalty Pharma’s IPO Gets Enthusiastic Reception, Jumping More Than 50% - BarronsRoyalty Pharma’s IPO Gets Enthusiastic Reception, Jumping More Than 50% - Barron's
www.barrons.com - June 16 at 7:29 PM
July 31st Options Now Available For Immunomedics (IMMU) - NasdaqJuly 31st Options Now Available For Immunomedics (IMMU) - Nasdaq
www.nasdaq.com - June 11 at 1:54 PM
This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.